Cancer Research Technology
Log in Register
Menu
Search
Small Molecules (Tool Compounds)

CS-5d Bcr-Abl and Btk small molecule kinase inhibitors

Invented by Cristian Salas
Invented at Pontificia Universidad Catolica de Chile
  • Datasheet
  • Inventor Info
Print

Info

Image thumbnail for CS-5d Bcr-Abl and Btk small molecule kinase inhibitors
Add an image
1. CS-5d (9-(Cyclopropylmethyl)-N6-(3,4-difluorophenyl)-N2-(4-(4-methylpiperazin-1-yl)phenyl)-9H-purine-2,6-diamine) 2. CS-5c (9-(Cyclopropylmethyl)-N6-(3-fluorophenyl)-N2-(4-(4-methylpiperazin-1-yl)phenyl)-9H-purine-2,6-diamine)
Add an image
Image thumbnail for CS-5d Bcr-Abl and Btk small molecule kinase inhibitors
Catalogue Number 160517
Antigen/Gene or Protein Targets Bcr-Abl and Btk kinases
Type Inhibitor
Relevance This compound inhibits in nanomolar scale for Bcr-Abl (40 nM) and sub-micromolar scale for Btk kinases (0,58 μM), both are related to the genesis and progression of myeloid and lymphoid leukaemia, respectively
Molecular Formula C26H28F2N8
lUPAC 9-(Cyclopropylmethyl)-N6-(3,4-difluorophenyl)-N2-(4-(4-methylpiperazin-1-yl)phenyl)-9H-purine-2,6-diamine
Molecular Weight (g/mol) 490.5509
Solubility DMSO
Research Area Cancer
Storage Away from UV light

References

There are 1 reference entries for this reagent.

View All References

References: 1 entry

Bertrand et al. 2020. Bioorg Chem. 94:103361. PMID: 31699386.

View  

Add a reference

References: 1 entry

Bertrand et al. 2020. Bioorg Chem. 94:103361. PMID: 31699386.

View  

Add a reference

Inventor Information